A Pilot, Open Label Trial Assessing the Safety and Efficacy of Betaine in Children With Peroxisome Biogenesis Disorders

Trial Profile

A Pilot, Open Label Trial Assessing the Safety and Efficacy of Betaine in Children With Peroxisome Biogenesis Disorders

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Betaine (Primary)
  • Indications Peroxisomal disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2016 Status changed from recruiting to completed.
    • 08 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top